Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Bernardo Website

Marcelino L. Bernardo

Selected Publications

1)  Seidel J, Bernardo ML, Wong KJ, Xu B, Williams MR, Kuo F, Jagoda EM, Basuli F, Li C, Griffiths GL, Green MV, Choyke PL.
Simultaneous ECG-gated PET imaging of multiple mice.
Nucl. Med. Biol. 2014.
2)  Smedley J, Turkbey B, Bernardo ML, Del Prete GQ, Estes JD, Griffiths GL, Kobayashi H, Choyke PL, Lifson JD, Keele BF.
Tracking the luminal exposure and lymphatic drainage pathways of intravaginal and intrarectal inocula used in nonhuman primate models of HIV transmission.
PLoS ONE. 9: e92830, 2014.
3)  Pang Y, Turkbey B, Bernardo M, Kruecker J, Kadoury S, Merino MJ, Wood BJ, Pinto PA, Choyke PL.
Intravoxel incoherent motion MR imaging for prostate cancer: An evaluation of perfusion fraction and diffusion coefficient derived from different b-value combinations.
Magn Res Med. 69: 553-62, 2013.
4)  Kines RC, Kobayashi H, Choyke PL, Bernardo ML.
Optical imaging of HPV infection in a murine model.
Methods Mol. Biol. 961: 141-50, 2013.
5)  Mena E, Turkbey B, Mani H, Adler S, Valera VA, Bernardo M, Shah V, Pohida T, McKinney Y, Kwarteng G, Daar D, Lindenberg ML, Eclarinal P, Wade R, Linehan WM, Merino MJ, Pinto PA, Choyke PL, Kurdziel KA.
11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation.
J. Nucl. Med. 53: 538-45, 2012.
6)  Turkbey B, Mani H, Aras O, Rastinehad AR, Shah V, Bernardo M, Pohida T, Daar D, Benjamin C, McKinney YL, Linehan WM, Wood BJ, Merino MJ, Choyke PL, Pinto PA.
Correlation of Magnetic Resonance Imaging Tumor Volume with Histopathology.
J. Urol. 188: 1157-63, 2012.
7)  Shah V, Turkbey B, Mani H, Pang Y, Pohida T, Merino MJ, Pinto PA, Choyke PL, Bernardo M.
Decision support system for localizing prostate cancer based on multiparametric magnetic resonance imaging.
Med Phys. 39: 4093-103, 2012.
8)  Kosaka N, Bernardo M, Mitsunaga M, Choyke PL, Kobayashi H.
MR and optical imaging of early micrometastases in lymph nodes: triple labeling with nano-sized agents yielding distinct signals.
Contrast Media Mol Imaging. 7: 247-53, 2012.
9)  Kramer-Marek G, Bernardo M, Kiesewetter DO, Bagci U, Kuban M, Aras O, Omer A, Zielinski R, Seidel J, Choyke P, Capala J.
PET of HER2-positive pulmonary metastases with 18F-ZHER2:342 affibody in a murine model of breast cancer: comparison with 18F-FDG.
J. Nucl. Med. 53: 939-46, 2012.
10)  Gordon SN, Kines RC, Kutsyna G, Ma ZM, Hryniewicz A, Roberts JN, Fenizia C, Hidajat R, Brocca-Cofano E, Cuburu N, Buck CB, Bernardo ML, Robert-Guroff M, Miller CJ, Graham BS, Lowy DR, Schiller JT, Franchini G.
Targeting the vaginal mucosa with human papillomavirus pseudovirion vaccines delivering simian immunodeficiency virus DNA.
J. Immunol. 188: 714-23, 2012.
11)  Trivedi H, Turkbey B, Rastinehad AR, Benjamin CJ, Bernardo M, Pohida T, Shah V, Merino MJ, Wood BJ, Linehan WM, Venkatesan AM, Choyke PL, Pinto PA.
Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer.
Urology. 79: 233-9, 2012.
12)  Liu W, Turkbey B, Sénégas J, Remmele S, Xu S, Kruecker J, Bernardo M, Wood BJ, Pinto PA, Choyke PL.
Accelerated T(2) mapping for characterization of prostate cancer.
Magn Reson Med. 65: 1400-6, 2011.
13)  Kojima C, Turkbey B, Ogawa M, Bernardo M, Regino CA, Bryant LH, Choyke PL, Kono K, Kobayashi H.
Dendrimer-based MRI contrast agents: the effects of PEGylation on relaxivity and pharmacokinetics.
Nanomedicine. [Epub ahead of print], 2011.
14)  Turkbey B, Xu S, Kruecker J, Locklin J, Pang Y, Bernardo M, Merino MJ, Wood BJ, Choyke PL, Pinto PA.
Documenting the location of prostate biopsies with image fusion.
BJU Int. 107: 53-7, 2011.
15)  Turkbey B, Xu S, Kruecker J, Locklin J, Pang Y, Shah V, Bernardo M, Baccala A, Rastinehad A, Benjamin C, Merino MJ, Wood BJ, Choyke PL, Pinto PA.
Documenting the location of systematic transrectal ultrasound-guided prostate biopsies: correlation with multi-parametric MRI.
Cancer Imaging. 11: 31-6, 2011.
16)  Turkbey B, Shah VP, Pang Y, Bernardo M, Xu S, Kruecker J, Locklin J, Baccala AA, Rastinehad AR, Merino MJ, Shih JH, Wood BJ, Pinto PA, Choyke PL.
Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?.
Radiology. 258: 488-95, 2011.
17)  .
MRI of localized prostate cancer: coming of age in the PSA era.
Diagn Interv Radiol. 18: 34-45, 2011.
18)  Turkbey B, Mani H, Shah V, Rastinehad AR, Bernardo M, Pohida T, Pang Y, Daar D, Benjamin C, McKinney YL, Trivedi H, Chua C, Bratslavsky G, Shih JH, Linehan WM, Merino MJ, Choyke PL, Pinto PA.
Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds.
J. Urol. 186: 1818-24, 2011.
19)  Gril B, Palmieri D, Qian Y, Anwar T, Ileva L, Bernardo M, Choyke P, Liewehr DJ, Steinberg SM, Steeg PS.
The B-Raf status of tumor cells may be a significant determinant of both antitumor and anti-angiogenic effects of pazopanib in xenograft tumor models.
PLoS ONE. 6: e25625, 2011.
20)  Sena LM, Fishman SJ, Jenkins KJ, Xu H, Brechbiel MW, Regino CA, Kosaka N, Bernardo M, Choyke PL, Kobayashi H.
Magnetic resonance lymphangiography with a nano-sized gadolinium-labeled dendrimer in small and large animal models.
Nanomedicine. 5: 1183-91, 2010.
21)  Bumb A, Regino CA, Perkins MR, Bernardo M, Ogawa M, Fugger L, Choyke PL, Dobson PJ, Brechbiel MW.
Preparation and characterization of a magnetic and optical dual-modality molecular probe.
Nanotechnology. 21: 175704, 2010.
22)  Turkbey B, Pinto PA, Mani H, Bernardo M, Pang Y, McKinney YL, Khurana K, Ravizzini GC, Albert PS, Merino MJ, Choyke PL.
Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation.
Radiology. 255: 89-99, 2010.
23)  Bumb A, Regino CA, Egen JG, Bernardo M, Dobson PJ, Germain RN, Choyke PL, Brechbiel MW.
Trafficking of a Dual-Modality Magnetic Resonance and Fluorescence Imaging Superparamagnetic Iron Oxide-Based Nanoprobe to Lymph Nodes.
Mol Imaging Biol. 2010.
24)  Shah V, Pohida T, Turkbey B, Mani H, Merino M, Pinto PA, Choyke P, Bernardo M.
A method for correlating in vivo prostate magnetic resonance imaging and histopathology using individualized magnetic resonance-based molds.
Rev Sci Instrum. 80: 104301, 2009.
25)  Nwe K, Xu H, Regino CA, Bernardo M, Ileva L, Riffle L, Wong KJ, Brechbiel MW.
A new approach in the preparation of dendrimer-based bifunctional diethylenetriaminepentaacetic acid MR contrast agent derivatives.
Bioconjug. Chem. 20: 1412-8, 2009.
26)  Turkbey B, Kobayashi H, Ogawa M, Bernardo M, Choyke PL.
Imaging of tumor angiogenesis: functional or targeted?.
AJR Am J Roentgenol. 193: 304-13, 2009.
27)  Young MR, Ileva LV, Bernardo M, Riffle LA, Jones YL, Kim YS, Colburn NH, Choyke PL.
Monitoring of tumor promotion and progression in a mouse model of inflammation-induced colon cancer with magnetic resonance colonography.
Neoplasia. 11: 237-46, 1p following 246, 2009.
28)  Martiniova L, Kotys MS, Thomasson D, Schimel D, Lai EW, Bernardo M, Merino MJ, Powers JF, Ruzicka J, Kvetnansky R, Choyke PL, Pacak K.
Noninvasive monitoring of a murine model of metastatic pheochromocytoma: a comparison of contrast-enhanced microCT and nonenhanced MRI.
J Magn Reson Imaging. 29: 685-91, 2009.
29)  Matsumoto S, Yasui H, Batra S, Kinoshita Y, Bernardo M, Munasinghe JP, Utsumi H, Choudhuri R, Devasahayam N, Subramanian S, Mitchell JB, Krishna MC.
Simultaneous imaging of tumor oxygenation and microvascular permeability using Overhauser enhanced MRI.
Proc. Natl. Acad. Sci. U.S.A. 106: 17898-903, 2009.
30)  Turkbey B, Thomasson D, Pang Y, Bernardo M, Choyke PL.
The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment.
Diagn Interv Radiol. doi: 10.4261/1305-3825.DIR.2537-08.1., 2009.
31)  Regino CA, Walbridge S, Bernardo M, Wong KJ, Johnson D, Lonser R, Oldfield EH, Choyke PL, Brechbiel MW.
A dual CT-MR dendrimer contrast agent as a surrogate marker for convection-enhanced delivery of intracerebral macromolecular therapeutic agents.
Contrast Media Mol Imaging. 3: 2-8, 2008.
32)  Boswell CA, Eck PK, Regino CA, Bernardo M, Wong KJ, Milenic DE, Choyke PL, Brechbiel MW.
Synthesis, characterization, and biological evaluation of integrin alphavbeta3-targeted PAMAM dendrimers.
Mol. Pharm. 5: 527-39, 2008.
Click Here to View Collapsed Bibliography.

This page was last updated on 6/17/2014.